Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples
Yiyu Dong1, Brandon J. Manley2, Maria F. Becerra1, Almedina Redzematovic3, Jozefina Casuscelli4, Daniel M. Tennenbaum4, Ed Reznik5, Song Han6, Nicole Benfante4, Ying-Bei Chen7, Maria E. Arcila5, Omer Aras8, Martin H. Voss3, Darren R. Feldman3, Robert J. Motzer3, Nicola Fabbri9, John H. Healey9, Patrick J. Boland9, Mohit Chawla10, Jeremy C. Durack11
1Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
2Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
3Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
4Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
5Computational Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
6Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
7Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
8Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
9Orthopedics Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
10Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
11Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
European Urology Focus
Tập 3
590-598
Thông tin tác giả